Searched for
ATORVASTATIN
Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...- US drugs site TrumpRx to list 600 generics as Donald Trump targets lower pricesPresident Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...
- Over 140,000 bottles of cholesterol-lowering drug recalled: Safety concerns with Atorvastatin calcium tabletsA major recall is underway for over 140,000 bottles of Atorvastatin Calcium Tablets. This popular cholesterol medication, the generic form ...
- Zydus receives final approvals from USFDA for skin ointment, heart medicineThe group also received a final nod for Amlodipine and Atorvastatin Tablets USP that is administered for heart and cholesterol-related case...
- Ranbaxy restarts generic Lipitor production for US marketPharma major Ranbaxy Laboratories restarts production of generic cholesterol lowering drug Atorvastatin as it looks to resume supplies to U...
- Ranbaxy recalls generic Lipitor from the US marketRanbaxy today said it is recalling its generic version of cholesterol-lowering drug Lipitor from US market leading to temporary disruption ...
- Dr Reddy's launches Atorvastatin calcium tablets in USDr Reddy's said that it has launched Atorvastatin calcium tablets, a bioequivalent generic version of Lipitor tablets in the US.
- Ranbaxy and Dr Reddy's to take a hit as Lipitor market shrinks 96%Analysts expect prices of atorvastatin, generic version of Lipitor, to drop further as additional players enter the market.
- Teva Pharmaceuticals will not be launching Atorvastatin, generic version of LipitorIsrael's Teva Pharmaceuticals will not launch atorvastatin, the generic version of Lipitor, that will help Indian cos Ranbaxy and Dr Reddy'...
- Ind-Swift, Wockhardt launch Atorvastatin tablets in UKInd-Swift Laboratories today said it has launched generic formulations of Atorvastatin in the UK in collaboration with Wockhardt.
- Ranbaxy Laboratories close to claiming 50% share of atorvastatin market in 6-month exclusivity periodA Ranbaxy spokesman declined comment but people familiar with Ranbaxy marketing plans said the company's share would cross 50% in about a m...
- Ranbaxy launches Atorvastatin in 3 European countriesRanbaxy Laboratories today said it has launched generic versions of Atorvastatin tablets, used for treating cholesterol, in Italy, Sweden a...
- Dr Reddy's to contest Pfizer's patent suit over atorvastatinDrug maker Dr Reddy's Laboratories will contest the patent infringement case filed against it by the global pharmaceutical giant Pfizer ove...
- Ranbaxy launches cholesterol drug in SAfricaRanbaxy Laboratories, India's largest drugmaker by sales, said on Tuesday its unit had launched atorvastatin, generic form of Pfizer Inc's ...
- NPPA fixes prices of formulation of AtorvastatinDrug price regulator, National Pharmaceutical Pricing Authority (NPPA) on Monday fixed the price of formulation of Atorvastatin, Clopidogre...
- Ranbaxy, Pfizer settle Lipitor litigation worldwideRanbaxy has settled most of its patent disputes with Pfizer, allowing it to launch a generic version of Lipitor from November 30, 2011. Ran...
- Ranbaxy loses battle for Lipitor patent in CanadaIn a setback for Ranbaxy in its global battle over the patent of Lipitor, a Canadian federal court has ruled that the company’s generic dru...
- Gets Norway nod to market Atorvastatin eRanbaxy Laboratories (RLL) announced that the Norwegian Appeals Court has given a favourable decision for Ranbaxy in its case against Pfize...
- Ranbaxy wins on all 4 Atorvastatin Patents in NorwayRanbaxy Laboratories Limited (RLL) announced that the Norwegian Appeals Court today handed down a favorable decision for Ranbaxy in its cas...
- Ranbaxy partially wins over Lipitor patentIn a partial win for country's biggest drugmaker Ranbaxy Laboratories in the ongoing patent litigation with Pfizer over atorvastatin (Lipit...
Load More
